Henan Lingrui Pharmaceutical Co Ltd (600285) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.043x

Based on the latest financial reports, Henan Lingrui Pharmaceutical Co Ltd (600285) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥140.12 Million ≈ $20.50 Million USD) by net assets (CN¥3.28 Billion ≈ $480.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Henan Lingrui Pharmaceutical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Henan Lingrui Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Henan Lingrui Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600285 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Henan Lingrui Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Lingrui Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Weaver Network Co Ltd SHG:603039	0.046x
OFG Bancorp NYSE:OFG	0.028x
Fleury S.A. SA:FLRY3	0.050x
JetBlue Airways Corp NASDAQ:JBLU	0.066x
Shenzhen Forms Syntron Information Co Ltd SHE:300468	0.070x
Punjab & Sind Bank NSE:PSB	-0.594x
HUTCHMED (China) Limited F:H7T1	-0.071x
Suzhou Douson Drilling & Production Equipment Co Ltd SHG:603800	-0.045x

Annual Cash Flow Conversion Efficiency for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Henan Lingrui Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.44 Billion ≈ $502.78 Million	CN¥553.88 Million ≈ $81.05 Million	0.161x	-43.31%
2024-12-31	CN¥3.08 Billion ≈ $450.74 Million	CN¥875.86 Million ≈ $128.17 Million	0.284x	-2.17%
2023-12-31	CN¥2.80 Billion ≈ $409.54 Million	CN¥813.43 Million ≈ $119.03 Million	0.291x	-10.94%
2022-12-31	CN¥2.56 Billion ≈ $374.38 Million	CN¥834.91 Million ≈ $122.17 Million	0.326x	-11.77%
2021-12-31	CN¥2.29 Billion ≈ $334.60 Million	CN¥845.69 Million ≈ $123.75 Million	0.370x	+90.63%
2020-12-31	CN¥2.32 Billion ≈ $339.80 Million	CN¥450.53 Million ≈ $65.93 Million	0.194x	-4.30%
2019-12-31	CN¥2.22 Billion ≈ $324.92 Million	CN¥450.15 Million ≈ $65.87 Million	0.203x	-2.67%
2018-12-31	CN¥2.09 Billion ≈ $306.49 Million	CN¥436.25 Million ≈ $63.84 Million	0.208x	+333.20%
2017-12-31	CN¥2.20 Billion ≈ $322.52 Million	CN¥105.97 Million ≈ $15.51 Million	0.048x	+60.53%
2016-12-31	CN¥2.11 Billion ≈ $309.08 Million	CN¥63.26 Million ≈ $9.26 Million	0.030x	-67.07%
2015-12-31	CN¥1.72 Billion ≈ $252.28 Million	CN¥156.82 Million ≈ $22.95 Million	0.091x	+14.19%
2014-12-31	CN¥1.56 Billion ≈ $228.39 Million	CN¥124.32 Million ≈ $18.19 Million	0.080x	-38.36%
2013-12-31	CN¥984.89 Million ≈ $144.12 Million	CN¥127.27 Million ≈ $18.62 Million	0.129x	+483.53%
2012-12-31	CN¥696.97 Million ≈ $101.99 Million	CN¥15.43 Million ≈ $2.26 Million	0.022x	-62.59%
2011-12-31	CN¥684.01 Million ≈ $100.09 Million	CN¥40.49 Million ≈ $5.92 Million	0.059x	+1163.14%
2010-12-31	CN¥709.69 Million ≈ $103.85 Million	CN¥-3.95 Million ≈ $-578.20K	-0.006x	-102.71%
2009-12-31	CN¥645.69 Million ≈ $94.48 Million	CN¥132.61 Million ≈ $19.40 Million	0.205x	+158.23%
2008-12-31	CN¥549.72 Million ≈ $80.44 Million	CN¥43.72 Million ≈ $6.40 Million	0.080x	+188.20%
2007-12-31	CN¥579.24 Million ≈ $84.76 Million	CN¥15.99 Million ≈ $2.34 Million	0.028x	-49.82%
2006-12-31	CN¥486.67 Million ≈ $71.21 Million	CN¥26.76 Million ≈ $3.92 Million	0.055x	-21.07%
2005-12-31	CN¥479.80 Million ≈ $70.21 Million	CN¥33.43 Million ≈ $4.89 Million	0.070x	-7.89%
2004-12-31	CN¥469.45 Million ≈ $68.70 Million	CN¥35.51 Million ≈ $5.20 Million	0.076x	+43.63%
2003-12-31	CN¥451.69 Million ≈ $66.10 Million	CN¥23.79 Million ≈ $3.48 Million	0.053x	-68.38%
2002-12-31	CN¥416.74 Million ≈ $60.98 Million	CN¥69.41 Million ≈ $10.16 Million	0.167x	+1861.90%
2001-12-31	CN¥401.79 Million ≈ $58.79 Million	CN¥3.41 Million ≈ $499.14K	0.008x	-5.34%
2000-12-31	CN¥408.46 Million ≈ $59.77 Million	CN¥3.66 Million ≈ $536.06K	0.009x	-88.42%
1999-12-31	CN¥62.08 Million ≈ $9.08 Million	CN¥4.81 Million ≈ $703.65K	0.077x	--

About Henan Lingrui Pharmaceutical Co Ltd

SHG:600285 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.84 Billion

CN¥12.58 Billion CNY

Market Cap Rank

#6447 Global

#1297 in China

Share Price

CN¥22.19

Change (1 day)

-1.25%

52-Week Range

CN¥19.37 - CN¥24.46

All Time High

CN¥26.75